To include your compound in the COVID-19 Resource Center, submit it here.

Mallincrodt acquiring Ocera

Mallinckrodt plc (NYSE:MNK) will acquire Ocera Therapeutics Inc. (NASDAQ:OCRX) for $1.52 per share in a deal

Read the full 169 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE